Apolipoprotein E and Cerebral Small Vessel Disease Markers in Patients With Intracerebral Haemorrhage.

Publication

Apolipoprotein E and Cerebral Small Vessel Disease Markers in Patients With Intracerebral Haemorrhage.

Journal Paper/Review - Jul 8, 2022

Hostettler Isabel, Seiffge David, Wong Andrew, Ambler Gareth, Wilson Duncan, Shakeshaft Clare, Banerjee Gargi, Sharma Nikhil, Jäger Hans Rudolf, Cohen Hannah, Yousry Tarek A, Al-Shahi Salman Rustam, Lip Gregory Y H, Brown Martin M, Muir Keith, Houlden Henry, Werring David

Citation

Hostettler I, Seiffge D, Wong A, Ambler G, Wilson D, Shakeshaft C, Banerjee G, Sharma N, Jäger H, Cohen H, Yousry T, Al-Shahi Salman R, Lip G, Brown M, Muir K, Houlden H, Werring D. Apolipoprotein E and Cerebral Small Vessel Disease Markers in Patients With Intracerebral Haemorrhage. Neurology 2022

Type

Journal Paper/Review (English)

Journal

Neurology 2022

Publication Date

Jul 8, 2022

Issn Electronic

1526-632X

Brief description/objective

We investigated the associations between Apolipoprotein E (APOE) genotype, intracerebral haemorrhage (ICH) and neuroimaging markers of cerebral amyloid angiopathy (CAA).